中国医药集团有限公司（SINOPHARM）2023年可持续发展报告（英文版）（51页）.pdf

1、1Quality as a PriorityValue SharingGreen OperationsEmbracing Diversity and EqualityResponsibility Management23Two Decades of Excellence,with an Unwavering Dedication to the Future Quality as a PriorityValue SharingGreen OperationsEmbracing Diversity and EqualityResponsibility Management目錄0103050204I

2、mplementing Responsibility Management and Strengthening the Foundation of Governance AppendixGreen Operations,Advocating Low Carbon PhilosophyValue Sharing,Co-Creating Responsible Value ChainQuality as a Priority,Serving Healthy ChinaEmbracing Diversity and Equality,Upholding a Cohesive WorkplaceSus

3、tainable Development StrategySustainable Development ManagementCompliance ManagementEnvironmental Management SystemAddressing Climate ChangeGreen ProductionAdvocating Green OfficeCollaborative Development of IndustriesSupply Chain ManagementActive Social ContributionProduct Quality ManagementEnsurin

4、g the Accessibility of Medical and HealthcareCustomer Rights ProtectionTechnology-Driven InnovationInformation Security ManagementEmployee Rights ProtectionPromoting Talent DevelopmentOccupational Health ProtectionEmployee CareResponsibility Performance TableHong Kong Stock Exchange ESG Reporting Gu

5、ide Content IndexThe SASACs ESG Special Report Reference Indicator System for State Owned Enterprises Holding Listed Companies Index TableReaders Feedback Form191927555661647779813539 414352676973748488 92 95DefinitionsAbout this ReportChairmans StatementLeading the Development of the Industry and P

6、ractising the Responsibility of Central Enterprises2023 ESG HighlightsAbout the CompanyFeatured Topic:Two Decades of Excellence,with an Unwavering Dedication to the Future01020304 05081412Two Decades of Excellence,with an Unwavering Dedication to the Future Quality as a PriorityValue SharingGreen Op